C164H245F3N34O7 — CID 161497885
4-tert-butyl-2,6-dimethoxypyridine;4-tert-butyl-6-[(1-methylazetidin-3-yl)methyl]pyrimidine;2-tert-butyl-6-[(4-methylpiperazin-1-yl)methyl]pyrazine;5-tert-butyl-4-methylpyridin-2-amine;2-tert-butyl-6-piperidin-4-yloxypyrazine;5-tert-butyl-N-(1H-pyrazol-4-yl)pyridine-2-carboxamide;4-[(2-tert-butyl-4-pyridinyl)methyl]morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;N-(5-tert-butylpyrimidin-2-yl)benzamide;(6-tert-butylpyrimidin-4-yl)-pyrrolidin-1-ylmethanone;5-tert-butyl-2-pyrrolidin-1-ylpyridine;5-tert-butyl-2-pyrrolidin-3-ylpyrimidine;2-tert-butyl-6-(trifluoromethyl)pyridine (PubChem CID 161497885) has the molecular formula C164H245F3N34O7 and a molecular weight of 2861.99 g/mol. Its IUPAC name is 4-tert-butyl-2,6-dimethoxypyridine;4-tert-butyl-6-[(1-methylazetidin-3-yl)methyl]pyrimidine;2-tert-butyl-6-[(4-methylpiperazin-1-yl)methyl]pyrazine;5-tert-butyl-4-methylpyridin-2-amine;2-tert-butyl-6-piperidin-4-yloxypyrazine;5-tert-butyl-N-(1H-pyrazol-4-yl)pyridine-2-carboxamide;4-[(2-tert-butyl-4-pyridinyl)methyl]morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;N-(5-tert-butylpyrimidin-2-yl)benzamide;(6-tert-butylpyrimidin-4-yl)-pyrrolidin-1-ylmethanone;5-tert-butyl-2-pyrrolidin-1-ylpyridine;5-tert-butyl-2-pyrrolidin-3-ylpyrimidine;2-tert-butyl-6-(trifluoromethyl)pyridine.
| Compound Name | 4-tert-butyl-2,6-dimethoxypyridine;4-tert-butyl-6-[(1-methylazetidin-3-yl)methyl]pyrimidine;2-tert-butyl-6-[(4-methylpiperazin-1-yl)methyl]pyrazine;5-tert-butyl-4-methylpyridin-2-amine;2-tert-butyl-6-piperidin-4-yloxypyrazine;5-tert-butyl-N-(1H-pyrazol-4-yl)pyridine-2-carboxamide;4-[(2-tert-butyl-4-pyridinyl)methyl]morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;N-(5-tert-butylpyrimidin-2-yl)benzamide;(6-tert-butylpyrimidin-4-yl)-pyrrolidin-1-ylmethanone;5-tert-butyl-2-pyrrolidin-1-ylpyridine;5-tert-butyl-2-pyrrolidin-3-ylpyrimidine;2-tert-butyl-6-(trifluoromethyl)pyridine |
|---|---|
| PubChem CID | 161497885 |
| Molecular Formula | C164H245F3N34O7 |
| Molecular Weight | 2861.99 g/mol |
| Exact Mass | 2859.98 |
| IUPAC Name | 4-tert-butyl-2,6-dimethoxypyridine;4-tert-butyl-6-[(1-methylazetidin-3-yl)methyl]pyrimidine;2-tert-butyl-6-[(4-methylpiperazin-1-yl)methyl]pyrazine;5-tert-butyl-4-methylpyridin-2-amine;2-tert-butyl-6-piperidin-4-yloxypyrazine;5-tert-butyl-N-(1H-pyrazol-4-yl)pyridine-2-carboxamide;4-[(2-tert-butyl-4-pyridinyl)methyl]morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;N-(5-tert-butylpyrimidin-2-yl)benzamide;(6-tert-butylpyrimidin-4-yl)-pyrrolidin-1-ylmethanone;5-tert-butyl-2-pyrrolidin-1-ylpyridine;5-tert-butyl-2-pyrrolidin-3-ylpyrimidine;2-tert-butyl-6-(trifluoromethyl)pyridine |
| SMILES | CC(C)(C)c1cc(C(=O)N2CCCC2)ncn1.CC(C)(C)c1cc(CN2CCOCC2)ccn1.CC(C)(C)c1ccc(C(=O)Nc2cn[nH]c2)nc1.CC(C)(C)c1ccc(N2CCCC2)nc1.CC(C)(C)c1ccc(N2CCNCC2)nc1.CC(C)(C)c1cccc(C(F)(F)F)n1.CC(C)(C)c1cnc(C2CCNC2)nc1.CC(C)(C)c1cnc(NC(=O)c2ccccc2)nc1.CC(C)(C)c1cncc(OC2CCNCC2)n1.CN1CC(Cc2cc(C(C)(C)C)ncn2)C1.CN1CCN(Cc2cncc(C(C)(C)C)n2)CC1.COc1cc(C(C)(C)C)cc(OC)n1.Cc1cc(N)ncc1C(C)(C)C |
| InChI | InChI=1S/C15H17N3O.C14H24N4.C14H22N2O.C13H16N4O.C13H21N3O.C13H19N3O.2C13H21N3.C13H20N2.C12H19N3.C11H17NO2.C10H12F3N.C10H16N2/c1-15(2,3)12-9-16-14(17-10-12)18-13(19)11-7-5-4-6-8-11;1-14(2,3)13-10-15-9-12(16-13)11-18-7-5-17(4)6-8-18;1-14(2,3)13-10-12(4-5-15-13)11-16-6-8-17-9-7-16;1-13(2,3)9-4-5-11(14-6-9)12(18)17-10-7-15-16-8-10;1-13(2,3)11-8-15-9-12(16-11)17-10-4-6-14-7-5-10;1-13(2,3)11-8-10(14-9-15-11)12(17)16-6-4-5-7-16;1-13(2,3)12-6-11(14-9-15-12)5-10-7-16(4)8-10;1-13(2,3)11-4-5-12(15-10-11)16-8-6-14-7-9-16;1-13(2,3)11-6-7-12(14-10-11)15-8-4-5-9-15;1-12(2,3)10-7-14-11(15-8-10)9-4-5-13-6-9;1-11(2,3)8-6-9(13-4)12-10(7-8)14-5;1-9(2,3)7-5-4-6-8(14-7)10(11,12)13;1-7-5-9(11)12-6-8(7)10(2,3)4/h4-10H,1-3H3,(H,16,17,18,19);9-10H,5-8,11H2,1-4H3;4-5,10H,6-9,11H2,1-3H3;4-8H,1-3H3,(H,15,16)(H,17,18);8-10,14H,4-7H2,1-3H3;8-9H,4-7H2,1-3H3;6,9-10H,5,7-8H2,1-4H3;4-5,10,14H,6-9H2,1-3H3;6-7,10H,4-5,8-9H2,1-3H3;7-9,13H,4-6H2,1-3H3;6-7H,1-5H3;4-6H,1-3H3;5-6H,1-4H3,(H2,11,12) |
| InChIKey | WGLKOGPZKLQNJL-UHFFFAOYSA-N |
| XLogP | 29.59 |
| TPSA | 470.57 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 208 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2861.99 |
| LogP ≤ 5 | 29.59 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 37 |